Self-care is a crucial part of managing heart failure and boosting quality of life. Here are some tips on what you should and ...

A groundbreaking discovery has emerged from the University of Arizona College of Medicine, offering a new and unexpected ...

Alleviant Medical announced that it received FDA investigational device exemption and breakthrough device designation for its ...

In a pioneering study at the University of Arizona, researchers discovered that some patients with artificial hearts show ...

It may open the door to new ways to treat and perhaps someday cure heart failure, the deadliest non-communicable disease on ...

A woman in her 30s suffering from heart failure was refused treatment by 22 hospitals before being admitted, emergency ...

XyloCor Therapeutics Inc., a Wayne gene therapy company, received $67.5 million from investors to support Phase 2 trials of a treatment designed to grow new blood vessels in the heart, XyloCor ...

Trials and Tribulations of Cell Therapy for Heart Failure, an Update on Ongoing Trials Dec. 2, 2024 — A critical review of cell-based and cell product-based therapies for the treatment of heart ...

Newer therapies for multiple conditions were major stories this year, but long-term HF survival gains seem to have vanished.

Adaptive cardiac devices are transforming the treatment of heart disease by enabling real-time monitoring and adaptive therapy adjustments. With their ability to provide continuous and accurate ...